Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma

BACKGROUND: Cell-free DNA (cfDNA) has the potential to serve as a non-invasive prognostic biomarker in some types of neoplasia. The investigation of plasma concentration of cfDNA may reveal its use as a valuable biomarker for risk stratification of diffuse large B-cell lymphoma (DLBCL). The present...

Descripción completa

Detalles Bibliográficos
Autores principales: Eskandari, Mahsa, Manoochehrabadi, Saba, Pashaiefar, Hossein, Zaimy, Mohammad Ali, Ahmadvand, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614089/
https://www.ncbi.nlm.nih.gov/pubmed/31309089
http://dx.doi.org/10.5045/br.2019.54.2.114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614089/
https://www.ncbi.nlm.nih.gov/pubmed/31309089
http://dx.doi.org/10.5045/br.2019.54.2.114

Ejemplares similares